Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Z Wec

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Cell Host & Microbe|January 9, 2022
Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodiesDenise Haslwanter, Gorka Lasso, Anna Z Wec, et al.
Science (New York, N.Y.)|September 10, 2016
A "Trojan horse" bispecific-antibody strategy for broad protection against ebolavirusesAnna Z Wec, Elisabeth K Nyakatura, Andrew S Herbert, et al.
Plos Pathogens|April 11, 2024
Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodiesAriel S Wirchnianski, Elisabeth K Nyakatura, Andrew S Herbert, et al.
Nature Microbiology|June 10, 2025
Viral evolution prediction identifies broadly neutralizing antibodies to existing and prospective SARS-CoV-2 variantsFanchong Jian, Anna Z Wec, Leilei Feng, et al.
Cell|May 20, 2017
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against EbolavirusesAnna Z Wec, Andrew S Herbert, Charles D Murin, et al.
Cell Host & Microbe|August 10, 2018
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola VirusBronwyn M Gunn, Wen-Han Yu, Marcus M Karim, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2020
Development of an antibody cocktail for treatment of Sudan virus infectionAndrew S Herbert, Jeffery W Froude, Ramon A Ortiz, et al.
Cell|May 20, 2017
Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of VulnerabilityXuelian Zhao, Katie A Howell, Shihua He, et al.
Nature|November 23, 2018
Protocadherin-1 is essential for cell entry by New World hantavirusesRohit K Jangra, Andrew S Herbert, Rong Li, et al.
Mbio|October 5, 2021
A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape MutantsDenise Haslwanter, M Eugenia Dieterle, Anna Z Wec, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cell Host & Microbe|January 9, 2022
Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodiesDenise Haslwanter, Gorka Lasso, Anna Z Wec, et al.
Science (New York, N.Y.)|September 10, 2016
A "Trojan horse" bispecific-antibody strategy for broad protection against ebolavirusesAnna Z Wec, Elisabeth K Nyakatura, Andrew S Herbert, et al.
Plos Pathogens|April 11, 2024
Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodiesAriel S Wirchnianski, Elisabeth K Nyakatura, Andrew S Herbert, et al.
Nature Microbiology|June 10, 2025
Viral evolution prediction identifies broadly neutralizing antibodies to existing and prospective SARS-CoV-2 variantsFanchong Jian, Anna Z Wec, Leilei Feng, et al.
Cell|May 20, 2017
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against EbolavirusesAnna Z Wec, Andrew S Herbert, Charles D Murin, et al.
Cell Host & Microbe|August 10, 2018
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola VirusBronwyn M Gunn, Wen-Han Yu, Marcus M Karim, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2020
Development of an antibody cocktail for treatment of Sudan virus infectionAndrew S Herbert, Jeffery W Froude, Ramon A Ortiz, et al.
Cell|May 20, 2017
Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of VulnerabilityXuelian Zhao, Katie A Howell, Shihua He, et al.
Nature|November 23, 2018
Protocadherin-1 is essential for cell entry by New World hantavirusesRohit K Jangra, Andrew S Herbert, Rong Li, et al.
Mbio|October 5, 2021
A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape MutantsDenise Haslwanter, M Eugenia Dieterle, Anna Z Wec, et al.
Pageof 3